About
Research
Patient Care
Education & Training
Community
Aug 07, 2024 | Healthline
Aspirin no substitute for healthy lifestyle to prevent colon cancer, says UCI Health surgeon
A new study has found that the regular use of aspirin could lower colorectal cancer risk, particularly among individuals with lifestyle risk factors such as smoking or obesity. UCI Health colorectal surgeon Dr. Jason A. Zell, who was not involved with the study, tells Healthline that the findings are unlikely to change the recommendations of the United States Preventative Services Task Force (USPSTF).
Aug 05, 2024 | OC Business Journal
UCI Develops Questionnaire for Different Languages
Researchers from the University of California, Irvine have developed and electronic assessment platform that aims to make language less of a barrier in healthcare.
Jul 11, 2024 | Very Well Health
Why Are So Many Minority Patients Declining Breast Cancer Treatment?
In a recent study, women of Asian descent were less likely to start breast cancer treatment quickly or even to accept treatment at all. Sora Park Tanjasiri, MPH, DrPH, a professor and associate director of cancer health disparities at the University of California Irvine Public Health, told Verywell that the interruption of family roles can be a significant factor in Asian patients’ decisions about care.
Jun 21, 2024 | LAist
Massive AAPI Cancer Study
The first national long-term study about cancer among Asian Americans has been launched to investigate health disparities among ethnic groups and uncover risk factors. “For example, Vietnamese have historically had higher rates of cervical cancer,” said Sora Tanjasiri, a public health professor at UC Irvine. “Koreans have higher rates of liver cancer and stomach cancer. You have to look at the nuances.”
May 28, 2024
Time Is on Cancer Immunotherapy’s Side
A new study led by a multidisciplinary research team at the University of California (UC), Irvine, demonstrates that the circadian clock can be leveraged to enhance the efficacy of checkpoint inhibitor cancer therapy.
Feb 15, 2024
Dr. Coombs Spotlights Recent CHIP Updates
Catherine Coombs, MD, an Associate Professor in the Division of Hematology/Oncology at the University of California, Irvine, School of Medicine, highlights recent studies in clonal hematopoiesis of indeterminate potential (CHIP) presented at the 65th American Society of Hematology Annual Meeting & Exposition in the fourth episode of the second season of “The HemOnc Pulse.”
Jan 19, 2024
Films featuring cancer stories can scare patients. A 10-year study hopes to help doctors better assuage fears.
Arash Rezazadeh Kalebasty, associate professor in the Division of Hematology and Oncology in the Department of Medicine, and co-authors, reviewed more than 100 films to discern if there was a disconnect between what was portrayed in films versus what they saw in clinical settings.
Dec 07, 2023
Routine post-treatment imaging of head and neck cancer patients may not be necessary, UCI-led study finds
UCI Health radiation oncologist Dr. Allen M. Chen and his co-authors reviewed the records of 501 patients who had radiation therapy at UCI Health between 2014 and 2022. Of those, they focused on 340 patients who had a negative scan indicating resolution of disease after completion of initial treatment. The study was published in JAMA Network Open.
Nov 22, 2023
Orange County chef thanks his daughter, medical teams for his chance at beating cancer
The UCI Health medical team, including Stefan Ciurea, professor in the Division of Hematology/Oncology, and director of the UCI Health Hematopoietic Stem Cell Transplant and Cellular Therapy Program at the UCI Chao Family Comprehensive Cancer Center, helps an Orange County chef in his fight against cancer.
Nov 21, 2023
What you need to know about male breast cancer
Dr. Israel De Alba, a hospitalist at UCI Health, spoke with Univision about breast cancer saying, “Breast cancer is much less common in men, [but] we can still get it and there are still risks. All men with [close family members] who have had breast cancer should consult with their physician. The ways of finding it are exactly the same as with women, through mammogram and ultrasound.”